What Analyst Projections for Key Metrics Reveal About Nutanix (NTNX) Q2 Earnings

Wall Street analysts forecast that Nutanix (NTNX) will report quarterly earnings of $0.29 per share in its upcoming release, pointing to a year-over-year increase of 141.7%. It is anticipated that revenues will amount to $551.82 million, exhibiting an increase of 13.4% compared to the year-ago quarter.

Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.

Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.

While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.

That said, let's delve into the average estimates of some Nutanix metrics that Wall Street analysts commonly model and monitor.

Analysts' assessment points toward 'Disaggregation of Revenue- Subscription revenue' reaching $515.42 million. The estimate suggests a change of +14.3% year over year.

It is projected by analysts that the 'Disaggregation of Revenue- Non-portable software revenue' will reach $9.40 million. The estimate suggests a change of -13.6% year over year.

According to the collective judgment of analysts, 'Disaggregation of Revenue- Professional services revenue' should come in at $24.97 million. The estimate indicates a change of +6.5% from the prior-year quarter.

The consensus among analysts is that 'Disaggregation of billings - Professional services billings' will reach $26.80 million. The estimate is in contrast to the year-ago figure of $22.63 million.

Analysts predict that the 'Disaggregation of billings - Subscription billings' will reach $573.50 million. The estimate compares to the year-ago value of $494.36 million.

Analysts forecast 'Total Billings' to reach $635.05 million. Compared to the present estimate, the company reported $529.10 million in the same quarter last year.

Based on the collective assessment of analysts, 'Disaggregation of billings - Non-portable software billings' should arrive at $8.97 million. The estimate compares to the year-ago value of $10.88 million.

View all Key Company Metrics for Nutanix here>>>

Nutanix shares have witnessed a change of +6.2% in the past month, in contrast to the Zacks S&P 500 composite's +5% move. With a Zacks Rank #3 (Hold), NTNX is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Nutanix (NTNX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.